glp-1 and gip/glp-1 receptor agonists Dual agonists: New advances for treating type-2 diabetes Spatiotemporal GLP-1 and GIP receptor

All that follows is from the above resource

Farxiga (Dapagliflozin) is a medication used to treat type 2 diabetes and more

Each vial contains 10mg of lyophilized Tirzepatide, manufactured under strict laboratory protocols in the United States

Discover how Retatrutide works through its triple-pathway mechanism (GLP-1, GIP, glucagon), how it affects metabolism, and when results may begin.

Well, thats exactly what happened with the GLP-1 receptor agonists

The success of these agents in preclinical models and clinical trials suggests a promising future for multiagonists in the treatment of metabolic diseases, with the most recent glucose-dependent insulinotropic peptide receptor:glucagon-like peptide 1 receptor:glucagon receptor (GIPR:GLP-1R:GCGR) triagonists rivaling the efficacy of bariatric surgery